558 COST-EFFECTIVENESS SIMULATION ANALYSIS OF TENOFOVIR DISOPROXIL FUMARATE (TENOFOVIR), LAMIVUDINE, ADEFOVIR DIPIVOXIL (ADEFOVIR) AND ENTECAVIR OF HBEAG NEGATIVE (-) PATIENTS WITH CHRONIC HEPATITIS-B (CHB) IN SPAIN | Publicación